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Background: There is a paucity of data of patients with severe functional mitral regurgitation (FMR) not treated with surgery. There is no data 
supporting surgery affects outcome in FMR. The MitraClip is a less invasive procedure, which may improve survival. 
methods: As off September 2012, all consecutive FMR patients on the MitraClip waitlist were assessed and their survival (from time of consent) 
was compared to consecutive FMR patients that underwent the MitraClip procedure (from time of procedure) in our center.
results: There were 52 patients on the waitlist and 99 patients that underwent the MitraClip procedure. Baseline characteristics were similar for 
age (74±10 years vs 75±11years, p=0.42), male (28 (54%) vs 61 (62%), p=0.36), Society of Thoracic Surgeons mortality score (10±10% vs 11±8%, 
p=0.64), New York Heart Association functional class ≥ III (40 (93%) vs 92 (93%), p=0.98), and MR grade ≥ 3+ (43 (100%) vs 98 (100%)). Post 
procedure MR ≤ 2+ was 93%. At a median follow up of 12 months, Kaplan-Meier estimate of actuarial survival was 75.1% for waitlist patients (vs 
88.2% following the MitraClip procedure, p=0.026).
conclusions: Patients with significant functional MR have high mortality. The MitraClip procedure may reduce mortality in these patients.
 
